Mydecine Announces 1-for-50 Reverse Stock Split

The board of directors of Mydecine Innovations Group Inc. MYCOF voted in favor of completing a reverse stock split. With this action, the company will consolidate all issued and outstanding shares on a base of 1-for-50.

According to Mydecine, the consolidation is expected to reduce the number of common shares from 268,515,954 to  5,370,319.

Although not yet approved by the NEO Exchange, the effective date for the consolidation and the announcement of the new CUSIP and ISIN numbers are expected to be completed within the next week.

Photo: Courtesy of Chris Liverani on Unsplash

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsPsychedelicsStock SplitMarketsmydecine
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.